Publications
5674 Results
- Journal / Conference
- Blood 128:616;American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), oral
- Year
- 2016
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0016
Continued excellent outcomes in previously untreated follicular lymphoma patients after treatment with CHOP plus rituximab or CHOP plus (131) iodine-tositumomab - long term follow-up of phase III randomized study SWOG S0016
- Journal / Conference
- Blood 128:896; American Society of Hematology Annual Meeting(December 3-6, 2016, San Diego, CA), oral
- Year
- 2016
- Research Committee(s)
- Leukemia
- Study Number(s)
- S0535
ATRA, arsenic trioxide (ATO), and gemtuzumab ozogamicin (GO) is safe and highly effective in patients with previously untreated high-risk acute promyelocytic leukemia (APL): final results of the SWOG/Alliance/ECOG S0535 trial
- Journal / Conference
- Blood 128:614; American Society of Hematology Annual Meeting (December 3-6, 2016, San Diego, CA), oral presentation
- Year
- 2016
- Research Committee(s)
- Lymphoma
- Study Number(s)
- S0801
Sequential RCHOP, radioimmunotherapy and rituximab maintenance improves early outcomes in advanced stage follicular lymphoma: 5 year outcomes from SWOG 0801 [http://www.bloodjournal.org/content/128/22/614]
- Journal / Conference
- San Antonio Breast Cancer Symposium (December 6-10, 2016, San Antonio, TX), oral
- Year
- 2016
- Research Committee(s)
- Symptom Management and Survivorship
- Study Number(s)
- S1202
Randomized, placebo controlled trial of duloxetine for aromatase inhibitor (AI)associated musculoskeletal symptoms (AIMSS) in early stage breast cancer (SWOG 1202)
- Journal / Conference
- European Society for Medical Oncology (October 7-11, 2016, Copenhagen, Denmark), invited oral presentation
- Year
- 2016
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- Study Number(s)
- S1609
Rare cancer research in the National Clinical Trials Network:The SWOG Experience
- Journal / Conference
- Journal of the National Cancer Institute Dec 31;109(3)pii: djw255
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040699
- PMC
- n/a - Review
- Study Number(s)
- S0016
Recommendations for clinical trial development in follicular lymphoma
- Journal / Conference
- Journal of the National Cancer Institute, Dec 31;109(1). pii: djw263
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040733
- PMC
- PMC n/a - Review
- Study Number(s)
- S0108, S0213, S0601
Recommendations for clinical trial development in mantle cell lymphoma
- Journal / Conference
- Journal of the National Cancer Institute Dec 31;109(2)
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040682
- PMC
- PMC n/a - Review
- Study Number(s)
- S0350, S1108
T-Cell Lymphoma: Recent Advances in Characterization and New Opportunities for Treatment
- Journal / Conference
- Journal of the National Cancer Institute Dec 16;108(12). pii: djw257. Print 2016 Dec.
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID27986884
- PMC
- pending
- Study Number(s)
- S0433, S0515, S9704
Beyond RCHOP: A blueprint for diffuse large B-cell lymphoma research
- Journal / Conference
- Journal of the National Cancer Institute, Dec 31;109(4). pii: djw249
- Year
- 2016
- Research Committee(s)
- Lymphoma
- PMID
- PMID28040700
- PMC
- PMC n/a - Review
- Study Number(s)
- S0816